NOF Corporation

4403

JP3753400005

Commodity Chemicals

We are working hard...

We are working hard to come back as soon as possible.
Nous travaillons dur pour revenir au plus vite.
Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
Estamos trabajando duro para volver lo antes posible.
Stiamo lavorando sodo per tornare il prima possibile.
Wij werken hard om zo snel mogelijk weer terug te zijn.

07-01	Tranche Update on NOF Corporation's Equity Buyback Plan announced on May 9, 2025.	CI
06-10	NOF Corporation repurchases 1.16 million shares

Tranche Update on NOF Corporation's Equity Buyback Plan announced on February 12, 2025.

Published on 25/03/2025 at 09:00

From February 12, 2025 to March 24, 2025, the company has repurchased 2,361,800 shares, representing 1% for ¥4,999.88 million. With this, the company has completed the repurchase of 2,361,800 shares, representing 1% for ¥4,999.88 million under the buyback announced on February 12, 2025.

We are working hard...

We are working hard to come back as soon as possible.
Nous travaillons dur pour revenir au plus vite.
Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
Estamos trabajando duro para volver lo antes posible.
Stiamo lavorando sodo per tornare il prima possibile.
Wij werken hard om zo snel mogelijk weer terug te zijn.

Latest news about NOF Corporation

Tranche Update on NOF Corporation's Equity Buyback Plan announced on May 9, 2025.	07-01	CI
NOF Corporation repurchases 1.16 million shares	06-10
NOF Repurchases Shares Worth 2.77 Billion Yen in May	06-02	MT
Nof Corp - To Buy Back Up To 2.14% Of Own Shares Worth 10 Billion Yen	05-09	RE
NOF Corporation Announces retirement of Shingo Unami as Outside Director , Effective June 27,2025	05-09	CI
NOF Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	05-09	CI
NOF Corporation announces an Equity Buyback for 5,000,000 shares, representing 2.14% for ¥10,000 million.	05-09	CI
NOF Corporation authorizes a Buyback Plan.	05-09	CI
Tranche Update on NOF Corporation's Equity Buyback Plan announced on February 12, 2025.	03-25	CI
NOF Corporation's Equity Buyback announced on February 12, 2025, has closed with 2,361,800 shares, representing 1% for ¥4,999.88 million.	03-24	CI
NOF Corporation announces an Equity Buyback for 2,500,000 shares, representing 1.06% for ¥5,000 million.	02-12	CI
Oyo Corp - To Buy Back Up To 2.52% Own Shares Worth 1.5 Billion Yen	02-12	RE
NOF Corporation authorizes a Buyback Plan.	02-12	CI
Tranche Update on NOF Corporation's Equity Buyback Plan announced on November 7, 2024.	12-24	CI
NOF Corporation's Equity Buyback announced on November 7, 2024, has closed with 2,088,300 shares, representing 0.88% for ¥4,999.98 million.	12-23	CI
NOF Repurchases 878,000 Shares for 2.3 Billion Yen	11-11	MT
NOF Corporation announces an Equity Buyback for 2,500,000 shares, representing 1.05% for ¥5,000 million.	11-07	CI
NOF Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	11-07	CI
NOF Corporation authorizes a Buyback Plan.	11-07	CI
NOF Corporation acquired an unknown stake in Phosphorex, LLC.	09/08/24	CI
NOF Completes 2 Billion Yen Share Buyback Program	24/06/24	MT
Tranche Update on NOF Corporation's Equity Buyback Plan announced on May 9, 2024.	24/06/24	CI
NOF Corporation's Equity Buyback announced on May 9, 2024, has closed with 970,000 shares, representing 0.41% for ¥1,999.83 million.	21/06/24	CI
NOF Repurchases 1 Billion Yen Worth of Shares in May	04/06/24	MT
NOF Corporation Announces Executive Retirements, Effective as of June 27, 2024	21/05/24	CI

Chart NOF Corporation

Duration

Period

4403: Dynamic Chart

Company Profile

NOF CORPORATION is mainly engaged in the functional chemical products business, life science business and others. The Company operates in three segments. The Functional Chemical segment is engaged in the manufacture and sale of fatty acids, fatty acid derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, petroleum chemicals, functional polymers, functional films, electronic materials and special rust prevention agents, as well as the rust prevention processing. The Life Science segment is engaged in the manufacture and sale of drug formulation materials for drug delivery systems (DDSs), edible oils and fats and health food products, among others. The Chemical segment is engaged in the manufacture and sale of industrial explosives, defense-related items, space-related products. The Company also operates in transportation business and real estate business.

Employees

3,997

Sector

Commodity Chemicals

Calendar

07-30 - Q1 2025 Earnings Release (Projected)

More about the company